Description: Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.
Home Page: www.pressurebiosciences.com
14 Norfolk Avenue
South Easton,
MA
02375
United States
Phone:
508 230 1828
Officers
| Name | Title |
|---|---|
| Mr. Richard T. Schumacher | Founder, Pres, CEO, Treasurer, Interim CFO, Clerk & Director |
| Dr. Alexander V. Lazarev Ph.D. | Chief Science Officer |
| Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. | Sr. VP of Engineering |
| John B. Hollister | Director of Sales & Marketing |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 9.9474 |
| IPO Date: | 1996-10-31 |
| Fiscal Year End: | December |
| Full Time Employees: | 12 |